Blog: A new era for refractive surgery in the United States: STAAR EVO ICL wins FDA approvalMay 22nd 2022
There’s a new alternative to LASIK in the United States. In March of 2022, the FDA approved STAAR Surgical’s EVO/EVO+ VISIAN Implantable Collamer Lens (ICL) and Toric Implantable Collamer Lens (TICL).
Patients with higher preoperative measurements of angle kappa and angle alpha may experience blurry vision, dry eyes following cataract surgeryApril 25th 2022
Anushka M. Raj, BS, second year medical student at the University of Oklahoma’s Dean McGee Eye Institute, presents "Inter-Device Measurement Reliability of Angle Kappa and Angle Alpha, Devices and Instruments" during ASCRS.
Identifying 3 barriers keeping families from accessing cataract treatment for their children in IndiaMarch 14th 2022
Dr. Rishi Raj Borah, Country Director with Orbis India, discusses recent research he co-authored showing the top 3 barriers keeping families from accessing cataract treatment for their children in India.
Lensar announces FDA acceptance of 510(k) submission for adaptive cataract treatment systemMarch 3rd 2022
The company notes that the system’s design includes a small footprint, enhanced ergonomics, superior imaging, dual-pulsed laser, and advanced astigmatism management tools.
Study finds progressive declines in vision in aging patients with diffractive multifocal IOLsJanuary 14th 2022
According to investigators, patients implanted with diffractive multifocal IOLs had notable declines in the corrected distance visual acuity, distance corrected near VA, and near area of focus with aging
AcuFocus receives Approvable Letter from FDA for small aperture IOLDecember 7th 2021
The company will begin commercialization of the IC-8 small aperture IOL, used for cataract patients, upon successful completion of the manufacturing facility inspections and receipt of an official approval order from the FDA, which the company estimates in Q2 2022.